Mefenamic acid attenuates intracerebroventricular streptozotocin-induced cognitive deficits in the rat: A behavioral analysis

Iranian Journal of Pharmacology and Therapeutics

Volumn 6, Issue 1, 2007, Pages 45-49

  Mojarad, Tourandokht Baluchnejad ^a   Roghani, Mehrdad ^b   Hosseinzadeh, Soheila ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Learning; Mefenamic acid; Memory; Spatial cognition rat; Streptozotocin

Indexed keywords

MEFENAMIC ACID; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFICACY; LEARNING DISORDER; MALE; MEMORY DISORDER; NONHUMAN; RAT;

EID: 44249126450     PISSN: 17352657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Veerendra Kumar MH, Gupta YK. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol 2003;30:336-342.
2. Standridge JB. Pharmacotherapeutic approaches to the prevention of Alzheimer's disease. Am J Geriatr Pharmacother 2004;2:119-132.
3. Grunblatt E, Hoyer S, Riederer P. Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm 2004;111:367-386.
4. Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behavioral Neuroscience 1998;112:1199-1208.
5. Pasinetti GM. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 1998;54:1-6.
6. Giovannini MG, Scali C, Prosperi C, Bellucci A, Pepeu G, Casamenti F. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol 2003;16:31-40.
7. Bradbury J. How NSAIDs might prevent Alzheimer's disease. Lancet Neurol 2004;3:638.
8. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004;23:159-169.
9. Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 2002;1:279-284.
10. Chen Q, Olney JW, Lukasiewicz PD, Almli T, Romano C. Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina. Neurosci Lett 1998;242:163-166.
11. Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N. Neuroprotective effects of non-steroidal antiinflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 2001;76:1895-1904.
12. Joo Y, Kim HS, Woo RS, Park CH, Shin KY, Lee JP, Chang KA, Kim S, Suh YH. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Mol Pharmacol 2006;69:76-84.
13. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego.
14. Inokuchi J, Mizutani A, Jimbo M, Usuki S, Yamagishi K, Mochizuki H, Muramoto K, Kobayashi K, Kuroda Y, Iwasaki K, Ohgami Y, Fujiwara M. Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP). Biochem Biophys Res Commun 1997;237:595-600.
15. Sharma M, Gupta YK. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 2002;71:2489-2498.
16. Fukui K, Omoi NO, Hayasaka T, Shinnkai T, Suzuki S, Abe K, Urano S. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci 2002;959:275-284.
17. Chu WZ, Qian CY. Expressions of Abeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats. Di Yi Jun Yi Da Xue Xue Bao 2005;25:168-170.
18. Shoham S, Bejar C, Kovalev E, Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Experimental Neurology 2003;184:1043- 1052.
19. Plaschke K, Hoyer S. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 1993;11:477-483.
20. Hoyer S, Hennenberg N, Knappm S, Lannert H, Martin E. Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann NY Acad Sci 1996;777:374-379.